Analysed GLAUKOS CORP (GKOS:NYSE) News Sources
Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus
23-09-2026
yahoo.com
Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus
07-10-2026
yahoo.com
Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Biologic for Retinal Diseases
08-10-2026
yahoo.com
Glaukos Advances Eye Care Portfolio with Three-Year Epioxa Trial Data and Licensing Deal
08-10-2026
yahoo.com
What is the current price of GLAUKOS CORP (GKOS:NYSE)?
The current price of GLAUKOS CORP (GKOS:NYSE) is $166.22.
GLAUKOS CORP (GKOS:NYSE) absolute price change since previous trading day?
The absolute price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is $0.53.
GLAUKOS CORP (GKOS:NYSE) percentage price change since previous trading day?
The percentage price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is 0.3199%.
What is the most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE)?
The most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE) is 86 out of 100.
What is the most recent average sentiment for GLAUKOS CORP (GKOS:NYSE)?
The most recent sentiment for GLAUKOS CORP (GKOS:NYSE) is .
SEC-8K** Filing Available For GLAUKOS CORP (GKOS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.